Except for cancers, HSP90 inhibitors are also promising in treating osteoarthritis, traumatic brain injury, neurodegenerative disease et al. (Siebelt et al., 2013; Alani et al., 2014; Ma et al., 2015). Here, HSP90AB1 is linked to cancer.